American Pharmacist Pfizer He said medical tests confirmed that he was an anti-HIV pill COVID-19 During the first few days after the onset of symptoms, hospitalization and mortality were reduced by almost 90% among those at risk.
The announcement comes in a field study of two doses of the Pfizer-BioNTech vaccine conducted in South Africa. 70% protect Against severe cases Omigron variant, Although it has a lower rate than other strains, is considered favorable by researchers.
The results of the new pill, which has not yet been approved in any country, are based on a study of more than 2,200 people and confirm that the initial findings were announced in early November.
Pfizer Announced that Your antiviral treatment, Will be marketed as Paxlovit, Encountered omigran variation in laboratory tests.
“It shows the potential of this (drug) candidate to save the lives of patients around the world,” Pfizer’s CEO Albert Borla was quoted as saying in a statement. “Anxious variants such as Omigran have increased the need for accessible treatment options for those infected with the virus.”
The investigation revealed the presence of the pill Reduces the need for hospitalization In high-risk adults COVID-19 The company reported 89% treatment within three days of onset of symptoms and 88% treatment within the first five days.
In all, there were 12 deaths in the placebo group – none receiving the drug – and no one in the group taking the drug.
Side effects were found in similar percentages in the group receiving treatment and placebo (23% and 24%, respectively), and they were generally mild.
There are encouraging results in a study among those at constant risk of developing serious illness COVID-19, As announced by the company, but that test is still ongoing.
The Paxlovit It is a combination of two drugs – nirmadrelvir, an experimental drug, and ridonavir, which is used against existing antivirals and against HIV. The treatment is to take 30 tablets within five days. (AFP)
All newsletter about corona virus
COVID-19 keeps everyone alert. Registration All about the corona virus in our newsletter, where you can find the most relevant daily data on the progress of the virus and the fight against its spread in the country and the world.
– ‘Vital Space’: Is the British variant of the Covit-19 too dangerous? Dr. Elmer Hurta responds:
“Passionate coffee fanatic. Social media lover. Twitter expert. Extreme music practitioner. Zombie junkie. Hardcore travel specialist.”